Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children
Elizabeth Goswami, Richard K Ogden, William E Bennett, Stuart L Goldstein, Richard Hackbarth, Michael J G Somers, Karyn Yonekawa, Jason Misurac, Elizabeth Goswami, Richard K Ogden, William E Bennett, Stuart L Goldstein, Richard Hackbarth, Michael J G Somers, Karyn Yonekawa, Jason Misurac
Abstract
Purpose: Medications are commonly associated with acute kidney injury (AKI). However, in both clinical practice and research, consideration of specific medications as nephrotoxic varies widely. The Nephrotoxic Injury Negated by Just-in-time Action quality improvement collaborative was formed to focus on prevention or reduction of nephrotoxic medication-associated AKI in noncritically ill hospitalized children. However, there were discrepancies among institutions as to which medications should be considered nephrotoxic. The collaborative convened a Nephrotoxic Medication (NTMx) Subcommittee to develop a consensus for the classification of nephrotoxic medications.
Summary: The NTMx Subcommittee initially included pediatric nephrologists, a pharmacist, and a pediatric intensivist. The committee reviewed NTMx lists from the collaborative and identified changes from the initial NTMx list. The NTMx Subcommittee conducted a literature review of the disputed medications and assigned an evidence grade based on the reported association with nephrotoxicity and the quality of the data. The association between medication exposure and AKI was also determined using administrative data from the Pediatric Health Information Systems database. The NTMx Subcommittee then came to a majority consensus regarding which medications should be included on the list. The subcommittee's recommendations were presented to the larger collaborative for approval, and consensus was achieved. The list continues to be reviewed and updated annually.
Conclusion: Formation of a multicenter quality-improvement initiative exposed current limitations as to which medications are considered nephrotoxic in clinical and research settings and presented an opportunity to approach this problem using an evidence-based process. A consensus definition of nephrotoxic-medication exposure was achieved.
Keywords: acute kidney injury; drug toxicity; nephrology; nephrotoxicity; pediatrics.
© American Society of Health-System Pharmacists 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
References
- Joyce EL, Kane-Gill SL, Fuhrman DY, Kellum JA. Drug-associated acute kidney injury: who’s at risk? Pediatr Nephrol. 2017; 32:59-69.
- Slater MB, Gruneir A, Rochon PA et al. . Risk factors of acute kidney injury in critically ill children. Pediatr Crit Care Med. 2016; 17:e391-8.
- Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005; 45:96-101.
- McGregor TL, Jones DP, Wang L et al. . Acute kidney injury incidence in noncritically ill hospitalized children, adolescents, and young adults: a retrospective observational study. Am J Kidney Dis. 2016; 67:384-90.
- Moffett BS, Goldstein SL. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol. 2011; 6:856-63.
- Goldstein SL, Kirkendall E, Nguyen H et al. . Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics. 2013; 132:e756-67.
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2:1-138.
- Goldstein SL, Mottes T, Simpson K et al. . A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int. 2016; 90:212-21.
- Mehta RL, Awdishu L, Davenport A et al. . Phenotype standardization for drug-induced kidney disease. Kidney Int. 2015; 88:226-34.
- Patzer L. Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol. 2008; 23:2159-73.
- Kaddourah A, Basu RK, Bagshaw SM et al. . Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med. 2017; 376:11-20.
- Sinclair EA, Yenokyan G, McMunn A et al. . Factors associated with acute kidney injury in children receiving vancomycin. Ann Pharmacother. 2014; 48:1555-62.
- Lacy C, Armstrong L, Goldman M et al. . Drug information handbook. Hudson, OH: Lexi-Comp; 2009.
- Guyatt GH, Oxman AD, Vist GE et al. . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336:924-6.
- Children’s Hospital Association. PHIS. (accessed 2019 Apr 5).
Source: PubMed